Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with type 2 diabetes

INTRODUCTION: The present phase 3, randomized, open‐label study compared the efficacy and safety of basal insulin peglispro with insulin glargine after 26 weeks of treatment when added to oral antihyperglycemic medications in insulin‐naïve Asian patients with type 2 diabetes. MATERIALS AND METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Investig
Hlavní autoři: Hirose, Takahisa, Cai, Zhihong, Yeo, Kwee Poo, Imori, Makoto, Ohwaki, Kenji, Imaoka, Takeshi
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754544/
https://ncbi.nlm.nih.gov/pubmed/28371567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12667
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky